A Study to Investigate the Pharmacokinetics (PK) of Modified Release (MR) Prototype Coated Tablet Formulations of GSK2982772

Clinical trial NCT03649412 · COMPLETED

Trial details

NCT number: NCT03649412
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Diseases

Start date: 2018-09-26
Primary completion: 2019-05-07
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.